Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
4.520
-0.050 (-1.09%)
Nov 21, 2024, 4:00 PM EST - Market closed
Portage Biotech Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 3.33 | 5.03 | 10.55 | 23.35 | 2.77 | 3.15 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 0.07 | Upgrade
|
Cash & Short-Term Investments | 3.33 | 5.03 | 10.55 | 23.35 | 2.77 | 3.22 | Upgrade
|
Cash Growth | -56.69% | -52.32% | -54.84% | 743.03% | -13.98% | -48.64% | Upgrade
|
Other Receivables | 0.02 | 0.04 | 0.24 | 0.21 | 0.68 | 0.56 | Upgrade
|
Receivables | 0.02 | 0.04 | 0.68 | 0.21 | 0.68 | 0.56 | Upgrade
|
Prepaid Expenses | 1.78 | 2.56 | 2.33 | 1.13 | 1.49 | 0.01 | Upgrade
|
Other Current Assets | 0.06 | 0.06 | 0.12 | 0.14 | - | - | Upgrade
|
Total Current Assets | 5.2 | 7.7 | 13.68 | 24.83 | 4.95 | 3.79 | Upgrade
|
Property, Plant & Equipment | 0.03 | 0.04 | - | - | - | - | Upgrade
|
Long-Term Investments | - | - | 2.89 | 9.08 | 9.14 | 8.63 | Upgrade
|
Goodwill | - | - | - | 43.32 | 43.32 | 43.32 | Upgrade
|
Long-Term Deferred Charges | - | - | 82.52 | 117.39 | 117.39 | 117.39 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.05 | 0.04 | 0.04 | 0.06 | 0.03 | Upgrade
|
Total Assets | 5.24 | 7.78 | 99.13 | 194.66 | 174.86 | 173.17 | Upgrade
|
Accounts Payable | 1.56 | 0.48 | 0.27 | 0.19 | 0.11 | 0.34 | Upgrade
|
Accrued Expenses | 1.31 | 2.31 | 1.56 | 0.52 | 1.79 | 0.7 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 1 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.15 | 0.3 | Upgrade
|
Current Portion of Leases | 0.04 | 0.04 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.1 | 0.05 | 0.03 | 0.07 | 1.15 | 0.22 | Upgrade
|
Total Current Liabilities | 3.01 | 2.88 | 1.87 | 0.78 | 3.21 | 2.57 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 3.36 | Upgrade
|
Long-Term Leases | - | 0.01 | - | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 10.56 | 28.45 | 24.05 | 21.6 | Upgrade
|
Other Long-Term Liabilities | 0.42 | 1.56 | 11.31 | - | - | - | Upgrade
|
Total Liabilities | 3.43 | 4.45 | 23.73 | 29.23 | 27.26 | 27.53 | Upgrade
|
Common Stock | 219.5 | 219.5 | 218.78 | 158.32 | 130.65 | 117.82 | Upgrade
|
Retained Earnings | -240.97 | -239.32 | -159.62 | -55.01 | -38.14 | -22.3 | Upgrade
|
Comprehensive Income & Other | 23.99 | 23.84 | 16.88 | 17.89 | 8.94 | 1.02 | Upgrade
|
Total Common Equity | 2.51 | 4.02 | 76.05 | 121.21 | 101.45 | 96.53 | Upgrade
|
Minority Interest | -0.7 | -0.69 | -0.65 | 44.23 | 46.15 | 49.11 | Upgrade
|
Shareholders' Equity | 1.81 | 3.33 | 75.4 | 165.43 | 147.6 | 145.64 | Upgrade
|
Total Liabilities & Equity | 5.24 | 7.78 | 99.13 | 194.66 | 174.86 | 173.17 | Upgrade
|
Total Debt | 0.04 | 0.05 | - | - | 0.15 | 4.66 | Upgrade
|
Net Cash (Debt) | 3.3 | 4.98 | 10.55 | 23.35 | 2.62 | -1.44 | Upgrade
|
Net Cash Growth | -55.46% | -52.76% | -54.84% | 791.30% | - | - | Upgrade
|
Net Cash Per Share | 3.27 | 5.15 | 13.08 | 35.76 | 4.47 | -2.63 | Upgrade
|
Filing Date Shares Outstanding | 1.05 | 1.05 | 0.89 | 0.85 | 0.67 | 0.59 | Upgrade
|
Total Common Shares Outstanding | 1.05 | 0.99 | 0.88 | 0.67 | 0.6 | 0.55 | Upgrade
|
Working Capital | 2.19 | 4.82 | 11.81 | 24.05 | 1.74 | 1.23 | Upgrade
|
Book Value Per Share | 2.39 | 4.07 | 86.39 | 181.59 | 167.91 | 175.71 | Upgrade
|
Tangible Book Value | 2.51 | 4.02 | 76.05 | 77.88 | 58.13 | 53.21 | Upgrade
|
Tangible Book Value Per Share | 2.39 | 4.07 | 86.39 | 116.68 | 96.21 | 96.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.